Ultradian Steroid Rhythms in Adrenal Incidentalomas
NCT: NCT07387419 · RECRUITING
Brief Summary
Twenty to 40% of adrenal incidentalomas are responsible for MACS (mild autonomous cortisol producing secretion). The biological tools used in current practice to explore MACS do not provide precise information on cortisol production abnormalities. This study is a comparative analysis of the dynamics/rhythmicity of interstitial cortisol and other steroid concentrations between MACS and non-secreting adenomas (ANS). Using the original and innovative U-RHYTHM system, interstitial fluid samples will be taken every 20 minutes for 24 to 48 hours from patients with MACS or non-secreting adenomas, and steroid assays will be performed in the perfusates to analyze steroid hormone production over 24 hours.
Frequently Asked Questions
What is Ultradian Steroid Rhythms in Adrenal Incidentalomas?
Ultradian Steroid Rhythms in Adrenal Incidentalomas is a clinical trial registered under NCT07387419. Current status: RECRUITING.
What is the status of NCT07387419?
The current status of NCT07387419 (Ultradian Steroid Rhythms in Adrenal Incidentalomas) is: RECRUITING.
When did Ultradian Steroid Rhythms in Adrenal Incidentalomas start?
Ultradian Steroid Rhythms in Adrenal Incidentalomas started on 2026-04-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.